SARS-CoV-2 Omicron Spike RBD Alexa Fluor-Labelled

Product Description

SARS-CoV-2 Omicron Spike RBD Protein Alexa Fluor 647-Labelled
Catalog number: B2010594
Lot number: Batch Dependent
Expiration Date: Batch dependent
Amount: 25 ug
Molecular Weight or Concentration: 30 kDa
Supplied as: Solution
Applications: molecular component of various serological and antigenic assays for SARS-CoV-2 and its variants
Storage: -20C
Keywords: SARS-CoV-2 B.1.1.529, Omicron RBD, Omicron Spike, Omicron RBD-Alexa Fluor 647
Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um.

Download SARS-CoV-2 Brochure

References:
1: Gendrot M, Andreani J, Duflot I, Boxberger M, Le Bideau M, Mosnier J, Jardot
P, Fonta I, Rolland C, Bogreau H, Hutter S, La Scola B, Pradines B. Methylene
blue inhibits replication of SARS-CoV-2 in vitro. Int J Antimicrob Agents. 2020
Dec;56(6):106202.

2: Dabravolski SA, Kavalionak YK. SARS-CoV-2: Structural diversity, phylogeny,
and potential animal host identification of spike glycoprotein. J Med Virol.
2020 Sep;92(9):1690-1694.

3: Corpet DE. Why does SARS-CoV-2 survive longer on plastic than on paper? Med
Hypotheses. 2021 Jan;146:110429.

4: Elizondo V, Harkins GW, Mabvakure B, Smidt S, Zappile P, Marier C, Maurano
MT, Perez V, Mazza N, Beloso C, Ifran S, Fernandez M, Santini A, Perez V,
Estevez V, Nin M, Manrique G, Perez L, Ross F, Boschi S, Zubillaga MN, Balleste
R, Dellicour S, Heguy A, Duerr R. SARS-CoV-2 genomic characterization and
clinical manifestation of the COVID-19 outbreak in Uruguay. Emerg Microbes
Infect. 2021 Dec;10(1):51-65.

5: Yang L, Pei RJ, Li H, Ma XN, Zhou Y, Zhu FH, He PL, Tang W, Zhang YC, Xiong
J, Xiao SQ, Tong XK, Zhang B, Zuo JP. Identification of SARS-CoV-2 entry
inhibitors among already approved drugs. Acta Pharmacol Sin. 2021
Aug;42(8):1347-1353.

6: Carlson CR, Asfaha JB, Ghent CM, Howard CJ, Hartooni N, Safari M, Frankel AD,
Morgan DO. Phosphoregulation of Phase Separation by the SARS-CoV-2 N Protein
Suggests a Biophysical Basis for its Dual Functions. Mol Cell. 2020 Dec
17;80(6):1092-1103.e4.

7: Han HJ, Nwagwu C, Anyim O, Ekweremadu C, Kim S. COVID-19 and cancer: From
basic mechanisms to vaccine development using nanotechnology. Int
Immunopharmacol. 2021 Jan;90:107247.

8: Kanjanasirirat P, Suksatu A, Manopwisedjaroen S, Munyoo B, Tuchinda P,
Jearawuttanakul K, Seemakhan S, Charoensutthivarakul S, Wongtrakoongate P,
Rangkasenee N, Pitiporn S, Waranuch N, Chabang N, Khemawoot P, Sa-Ngiamsuntorn
K, Pewkliang Y, Thongsri P, Chutipongtanate S, Hongeng S, Borwornpinyo S,
Thitithanyanont A. High-content screening of Thai medicinal plants reveals
Boesenbergia rotunda extract and its component Panduratin A as anti-SARS-CoV-2
agents. Sci Rep. 2020 Nov 17;10(1):19963.

9: Benedetti F, Pachetti M, Marini B, Ippodrino R, Ciccozzi M, Zella D. SARS-
CoV-2: March toward adaptation. J Med Virol. 2020 Nov;92(11):2274-2276.
10: Sasaki M, Uemura K, Sato A, Toba S, Sanaki T, Maenaka K, Hall WW, Orba Y,
Sawa H. SARS-CoV-2 variants with mutations at the S1/S2 cleavage site are
generated in vitro during propagation in TMPRSS2-deficient cells. PLoS Pathog.
2021 Jan 21;17(1):e1009233.

Products Related to SARS-CoV-2 Omicron Spike RBD Protein Alexa Fluor 647-Labelled: Proteins